Victoria Muñoz, BS, Quirónsalud Hospital Bizkaia, Erandio, Spain.
Carmen Martinez, BS, Quirónsalud Hospital Bizkaia, Erandio, Spain.
Begoña Echevarria, BS, Quirónsalud Hospital Bizkaia, Erandio, Spain.
Mª Isabel Fernández, BS, Quirónsalud Hospital Bizkaia, Erandio, Spain.
Ander Pino, MSc, BTI Biotechnology Institute, Vitoria, Spain.
Eduardo Anitua, PhD, MD, DDS, BTI Biotechnology Institute, Vitoria, Spain and Eduardo Anitua Foundation, Vitoria, Spain.
Correspondence: Eduardo Anitua, PhD, MD, DDS, Fundación Eduardo Anitua, Jacinto Quincoces 39, Vitoria, Spain ([email protected]).
Eduardo Anitua is the scientific director of, and Ander Pino is a researcher at, BTI Biotechnology Institute, the company that has developed the PRGF-Endoret technology. Victoria Muñoz, Carmen Martinez, Begoña Echevarria, and Mª Isabel Fernandez declare no conflict of interest.